Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,088 recruiting studies in this area right now.
By phase
- Not applicable4,195
- Phase 2595
- Phase 1411
- Phase 3325
- Phase 4251
- Phase 1/Phase 2245
- Phase 2/Phase 366
Top conditions
- Ovarian Cancer336
- Cervical Cancer223
- Endometrial Cancer207
- Bladder Cancer187
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy128
- Chronic Kidney Diseases122
- Breast Cancer111
- Chronic Kidney Disease107
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong33
Where studies are running
- California349
- Alabama153
- Texas120
- Massachusetts118
- New York115
- Arizona106
- Florida103
- Maryland88
- Colorado85
- Illinois79
Recruiting studies6,088 total
- NCT06924450Recruiting
Modified mesh for stress incontinence surgery
This trial tests whether a modified mesh improves success rates in a common sling surgery for stress urinary incontinence. It is for women who have not improved with non-surgical treatments and are already planning to have this procedure.
VanAges 18 years+ - NCT06931184Enrolling by invitation
Self-sampling for cervical cancer after missed screening
This trial offers a self-sampling test for cervical cancer screening. It is for women who missed their first screening and received a reminder letter. Instead of going to a clinic, you can collect a sample at home and send it in.
Tampere, PirkanmaaAges 30–65 - NCT06925724RecruitingPhase 2
Ivonescimab for advanced endometrial or cervical cancer
This study tests a new drug called ivonescimab for people with advanced endometrial or cervical cancer that has progressed after standard platinum-based chemotherapy. Ivonescimab is an investigational immunotherapy that may help your immune system fight the cancer.
Basking Ridge, New JerseyAges 18 years+ - NCT06929975Enrolling by invitation
Podcast training to reduce birth fear in couples
This study tests whether listening to podcasts about birth can help reduce fear in expecting couples. It is for first-time mothers and their partners who are in the second trimester of pregnancy.
AğrıAges 19–35 - NCT06930755RecruitingPhase 1
Study of an oral drug for recurrent ovarian cancer
This study tests a new oral drug called NMS-03305293 for women with recurrent ovarian cancer. It may work by targeting a specific protein involved in cancer growth. You may be eligible if you have high-grade serous ovarian cancer, have had limited prior treatments, and do not have a BRCA mutation.
Peoria, IllinoisAges 18 years+ - NCT06926075RecruitingPhase 1/Phase 2
Early trial of KESONOTIDE™ for solid tumors
This trial tests a new tablet called KESONOTIDE™ for people with solid tumors that have spread. The goal is to see if it can help when other treatments have stopped working or are not an option.
Kogarah, New South WalesAges 18 years+ - NCT06047600Recruiting
Digital nursing support for kidney tumor surgery
This trial tests if a digital tool can improve care coordination before and after surgery for kidney tumors. It may help patients feel more supported during their treatment journey.
AngersAges 18 years+ - NCT05942027RecruitingPhase 4
CoQ10 in early-to-moderate kidney disease with high urine protein
This study tests whether taking coenzyme Q10 can improve chronic kidney disease in adults with moderate kidney function and higher urine protein. It also looks at safety, especially for blood pressure and potassium levels.
Tanta, Capital of Gharbia Governorate.Ages 18 years+ - NCT04183101RecruitingPhase 2
Aliskiren vs enalapril for C3 kidney inflammation
This trial tests whether aliskiren works better or as well as enalapril to treat C3 glomerulopathy/dense deposit disease confirmed by a kidney biopsy. It may help by improving kidney outcomes in people with this specific kidney condition.
GothenburgAges 6 years+ - NCT06379698Recruiting
3D printed kidney models for robot-assisted surgery
This trial is testing if a 3D printed model of your kidney helps surgeons better plan and perform robot-assisted partial nephrectomy (removing only part of the kidney) for kidney tumors.
BordeauxAges 18 years+ - NCT06919965RecruitingPhase 3
TAR-210 vs. standard bladder chemo for high-risk bladder cancer
This trial compares a new drug called TAR-210, given directly into the bladder, to standard chemotherapy for people with a specific type of high-risk bladder cancer that has not invaded muscle. It tests if TAR-210 can be more effective with fewer side effects.
Sun City, ArizonaAges 18 years+ - NCT06915025RecruitingPhase 3
Study of a new drug for advanced ovarian cancer
This trial tests a new drug called IMNN-001 combined with standard chemotherapy for women with advanced ovarian, fallopian tube, or peritoneal cancer. The goal is to see if adding this drug can improve safety and effectiveness.
Orlando, FloridaAges 18 years+ - NCT06912126Recruiting
The Maggie Project: Exploring vaginal microbiome origins and heredity
This study looks at how the vaginal microbiome is passed between family members or close contacts. If you are a Belgian woman in good health who can join with her mother and another person, you may help researchers understand what shapes this bacteria community.
AntwerpAges 10 years+ - NCT06919718Recruiting
Vitamin D supplements for new mothers in Idaho
This trial tests whether taking vitamin D supplements can improve mental health and change the nutrients in breast milk for mothers living in Idaho.
Coeur d'Alene, IdahoAges 18–64 - NCT06914297RecruitingPhase 2
Study of TQB2450 plus progestin for uterine cancer patients wanting to keep fertility
This trial tests a combination of an immunotherapy drug (TQB2450) with a hormone treatment (progestin) for patients with a specific type of early-stage uterine cancer who wish to preserve their ability to have children. The goal is to see if this approach is safe and effective.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT06917703Enrolling by invitation
Mobile health program for first-time pregnant women
This study tests a mobile health program to help first-time pregnant women manage weight and blood sugar. The program uses your phone to provide support and track data, aiming to support a healthy pregnancy.
Taipei, TaiwanAges 18–50 - NCT06914791Enrolling by invitation
Pelvic floor rehab for sportswomen
This trial tests two different rehab exercises for the pelvic floor in sportswomen. It aims to find which approach works best to strengthen that area and help with recovery.
Fara in SabinaAges 18–50 - NCT06915792RecruitingPhase 4
Postpartum blood pressure medication and stopping study
This trial compares two blood pressure medicines, nifedipine and labetalol, to see which works better for new mothers with high blood pressure after giving birth. It aims to find the best way to safely stop medicine as blood pressure improves.
Los Angeles, CaliforniaAges 18–64 - NCT06918275Enrolling by invitation
Keyhole surgery for C-section scar defect repair
This study tests a keyhole surgery (laparoscopy) to repair a C-section scar defect (isthmocele). It is for women who have symptoms from the defect and want to preserve their ability to get pregnant in the future.
Istanbul, IstanbulAges 18–45 - NCT06919692Recruiting
Lying on left side for fetal growth restriction
This study tests if lying on your left side can help improve blood flow and oxygen for babies with fetal growth restriction (FGR), a condition where the baby is smaller than expected. If you are pregnant with one baby, between 24 and 34 weeks, and your baby is in the bottom 10% for weight, you may qualify.
Aurora, ColoradoAges 18–65 - NCT06921720Recruiting
Phosphate diabetes muscle study using phosphorus scan
This study uses a special MRI scan to look at phosphorus levels in the muscles of people with phosphate diabetes (a condition where the body loses too much phosphate through the kidneys). It aims to better understand how this condition affects muscles and may help guide future treatments.
BronAges 10 years+ - NCT06912490Recruiting
Predicting kidney function from amniotic fluid in babies with kidney issues
This study uses a sample of the fluid around your baby (amniotic fluid) to try to predict how well their kidneys will work after birth. It is for pregnancies where both kidneys have been found to have a structure problem.
ToulouseAges Any age - NCT06912477Recruiting
Blood vessel health in preeclampsia prognosis
This study looks at blood vessel function in pregnant people with preeclampsia to see if it can help predict outcomes. It involves non-invasive measures and routine blood tests.
HeidelbergAges 18 years+ - NCT06912776Recruiting
Visual education tool for postpartum warning signs
This study tests a new visual education tool to help new mothers recognize and report urgent warning signs after childbirth. If you qualify, you'll learn how to spot symptoms that may need quick medical attention.
Chicago, IllinoisAges 18 years+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,088 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,891 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.